English	French	Notes	Complete/Exclude
   Venous Invasion (V):  			
   Other Stage:  			
Physician Staging:  			
   Tumor Size:  			
   Pathologic Extension:  			
   Lymph Nodes: 			
Metastasis 1:  			
   Regional Nodes Examined:  			
Metastasis 2:  			
   Regional Nodes Positive:  			
Metastasis 3:  			
   General Summary Stage:  			
   Peripheral Blood Involvement:  			
   Associated With HIV:  			
   Surgical Dx/Staging Proc:       			
   Surgical Dx/Staging Proc Date:  			
   Surg Dx/Staging Proc @Fac:      			
   Surg Dx/Staging Proc @Fac Date: 			
   Date of no treatment:           			
   Surgery of Primary (R):         			
   Surgery of Primary (F):         			
   Surgery of Primary Date:        			
   Surgery of Primary @Fac (R):    			
   Surgery of Primary @Fac (F):    			
   Surgery of Primary @Fac Date:   			
    Surgical Approach (R):          			
   Surgical Margins:               			
   Scope of LN Surgery (R):        			
   Scope of LN Surgery (F):        			
   Scope of LN Surgery Date:       			
   Scope of LN Surgery @Fac (R):   			
   Scope of LN Surgery @Fac (F):   			
   Scope of LN Surgery @Fac Date:  			
   Surg Proc/Other Site (R):       			
   Surg Proc/Other Site (F):       			
   Surg Proc/Other Site Date:      			
   Surg Proc/Other Site @Fac (R):  			
   Surg Proc/Other Site @Fac (F):  			
   Surg Proc/Other Site @Fac Date: 			
   Date of Surgical Discharge:     			
   Reason for No Surgery:          			
   RX Text-Surgery: 			
   Date Radiation Started:         			
   Location of Radiation Tx:       			
   Radiation Treatment Volume:     			
   Regional Treatment Modality:    			
   Regional Dose: cGy:             			
   Boost Treatment Modality:       			
   Boost Dose: cGy:                			
   Number of Txs to this Volume:   			
   Date Radiation Ended:           			
   Radiation @Fac Date:            			
   Radiation/Surgery Sequence:     			
   Reason for No Radiation:        			
   RX Text-Radiation (Beam):  			
   RX Text-Radiation Other:  			
   Chemotherapy Date:  			
   Chemotherapy @Fac Date:  			
   RX Text-Chemo:  			
   Hormone Therapy:  			
   Hormone Therapy Date:  			
   Hormone Therapy @Fac:  			
   Hormone Therapy @Fac Date:  			
   RX Text-Hormone:  			
   Immunotherapy Date:  			
   Immunotherapy @Fac Date:  			
   RX Text-BRM:  			
   Hema Trans/Endocrine Proc:  			
   Hema Trans/Endocrine Proc Date:  			
   Other Treatment:  			
   Other Treatment Date:  			
   Other Treatment @Fac:  			
   Other Treatment @Fac Date:  			
   RX Text-Other:  			
   Pain Assessment:  			
   Palliative Procedure:  			
   Palliative Procedure @Fac:  			
   Protocol Participation:  			
   Year Put on Protocol:  			
   Text Dx Proc-Phys.Exam:  			
   Text Dx Proc-Xray/Scan:  			
   Text Dx Proc-Operations:  			
   Text Dx Proc-Lab Tests:  			
   Text Dx Proc-Endoscopy:  			
   Text Dx Proc-Path/Cyto:  			
   Date of First Recurrence:  			
   Type of First Recurrence:  			
   Distant Site 1:  			
   Distant Site 2:  			
   Distant Site 3:  			
   Subsequent Recurrence Date:  			
   Type of Subsequent Recurrence:  			
SUBSEQUENT COURSE OF THERAPY			
   Date Started:  			
   Surgery of Primary Site:  			
   Scope of Lymph Node Surg:  			
   Number of Nodes Removed:  			
   Surgery of Other Sites/Nodes:  			
   Radiation Sequence:  			
   Radiation Therapy to CNS:  			
OTHER PRIMARY SITES			
Abst Status			
No Other Primary Sites			
PERSONAL DATA			
             Address at Dx: 			
      Address at Dx - Supp: 			
           City/Town at Dx: 			
     Place of Birth: 			
               State at Dx: 			
         Postal Code at Dx: 			
Marital Status at Dx: 			
              County at Dx: 			
Primary Payer at Dx: 			
        Next of Kin: 			
          Abstract Status : 			
 Abstract Date: 			
Abstracted by: 			
Agent Orange Exposure:  			
Ionizing Radiation Exposure:  			
          Chemical Exposure:  			
          Asbestos Exposure:  			
       Persian Gulf Service:  			
        Middle East Service:  			
            Somalia Service:  			
Comorbidity/Complication #1:  			
Comorbidity/Complication #2:  			
Comorbidity/Complication #3:  			
Comorbidity/Complication #4:  			
Comorbidity/Complication #5:  			
Comorbidity/Complication #6:  			
EMPLOYMENT HISTORY			
Usual Industry:  			
TOBACCO AND ALCOHOL USAGE			
  TOBACCO HISTORY:  			
Type of Tobacco User:  			
CHEWING TOBACCO			
MORE THAN 1 TYPE			
Pack-Years:  			
Year Quit Tobacco Use:  			
  ALCOHOL HISTORY:  			
Type of Alcohol User:  			
HARD LIQUOR			
MODERATE/SOCIAL			
SERIOUS/HEAVY			
Years of Alcohol Use:  			
Drinks Per Day:  			
Year Quit Drinking:  			
CANCER FAMILY HISTORY: 			
   Family member with cancer:  			
PHYSICIAN CONTACTS 			
   Following Physician:  			
       Primary Surgeon:  			
   QA Selected:  			
   QA Reviewer:  			
   QA Date:  			
   QA Review:  			
   QA Findings: 			
FOLLOW-UP HISTORY			
   Date of Last Contact:  			
   Last Tumor Status:  			
   Date of Death:  			
   Cause of Death:  			
   ICD Cause of Death:  			
   State Death Cert:  			
   ICD Revision:  			
   Place of Death:  			
   Care Center at Death:  			
   Autopsy Date/Time:  			
   Autopsy No.:  			
TUMOR Status at DEATH (Multiple Primaries)			
   Last Contact:  			
  Follow-up Method:  			
Readmission (inpatient or outpatient)			
   Vital Status:  			
  Next Follow-up Method:  			
   Quality of Survival:  			
  Unusual Follow-up Method:  			
1st unusual method			
2nd unusual method			
Date Entered:  			
Registrar:  			
   Following Registry:  			
 Select year			
@#ACCESSION YEAR,ACC/SEQ NUMBER			
ANNUAL Patient Index - ACOS Required (132col)			
#@ACCESSION YEAR,@PATIENT NAME			
ANNUAL Patient List by Class of Case (80c)			
@ACCESSION YEAR,+#@CLASS CATEGORY,+CLASS OF CASE,@PATIENT NAME			
ANNUAL Site/Gp Listing by ICDO-Topography/Histology			
@ACCESSION YEAR,+@CLASS CATEGORY,#SITE/GP;S1;C20,+ICDO-TOPOGRAPHY;C12,+HISTOLOGY (ICD-O-2);C9			
ANNUAL Site/GP Index by ICDO-Topography (132)			
@ACCESSION YEAR,@CLASS CATEGORY,#@SITE/GP			
Annual report - sorted first by Accession year			
Then by Class Category (Non-analytic/Analytic)			
Then by Status, Site/GP, and Diagnosis Age Gp.			
Enter four digit ACCESSION YEAR,			
for Class category: either 'A'			
for Analytic, or first to last.			
YOU may customize your own reports using this option			
See the FileManager Manual for detailed instructions			
CREATE CUSTOM REPORT for 			
There is no ICDO-TOPOGRAPHY for this primary.			
There is currently no PCE for this primary site			
nor is it a 1997 Non-Hodgkin's Lymphoma or 1999			
Melanoma.			
'00/00/00' is ambiguous, enter a 4 digit year.			
'88/88/88' is ambiguous, enter a 4 digit year.			
'99/99/99' is ambiguous, enter a 4 digit year.			
LOOKING FOR Address at Diagnosis - Get from MAS			
DONE CONVERTING ADDRESS AT DX			
 Select Type Abstract			
 Select Option			
 Select Patient to Print:  			
ALL PATIENT ABSTRACTS			
 Select Site/GP to Print: 			
ONCOLOGY MULTIPLE SITE ABSTRACTS			
 Select Site/GP: 			
SITE GPS for 19			
Timed out...			
ALL ABSTRACTS for 19			
 Select Beginning Date:			
 Choose Ending Date:			
ONCOD*			
ABSTRACTS BY DXDT			
Define an AUTHORIZED QA USER in the ONCOLOGY SITE PARAMETERS file			
Not an AUTHORIZED QA USER			
Time frame: ABSTRACT DATE (Completed)			
 Select Beginning Date 			
 Choose Ending Date 			
10% QA REPORT-1			
10% QA REPORT-2			
CANNOT DELETE THIS ENTRY			
ONCO ABSTRACT NOT-COMPLETE			
ONCO ACCREG-ACOS80			
ONCO ACCREG-EOVA132			
ONCO ACCREG-SITE/GP80			
ONCO ACOS DOCUMENTATION			
ONCO AJCC SUMMARY STAGE GPS			
ONCO ANNUAL ACCREG80			
ONCO ANNUAL ACCREG80-HDR			
ONCO ANNUAL CLASS/PATIENT			
ONCO ANNUAL CLASS/PATIENT-HDR			
ONCO ANNUAL HIST/SITE/ICDO			
ONCO ANNUAL ICDO/STAGE/TX			
ONCO ANNUAL PATIENT INDX			
ONCO ANNUAL PATIENT INDX-HDR			
ONCO ANNUAL PATIENT INFO			
ONCO ANNUAL PATIENT INFO-HDR			
ONCO ANNUAL SITE/GP			
ONCO ANNUAL SITE/GP-HDR			
ONCO ANNUAL SITE/ICDT/ICDM			
ONCO ANNUAL SITE/STAGE/TX			
ONCO ANNUAL SITE/STAGE/TX-HDR			
ONCO ANNUAL SITE/STG/TX			
ONCO ANNUAL TREATMENT			
ONCO CASEFINDING-HDR			
ONCO CONTACT LIST-A			
ONCO CONTACT LIST-T			
ONCO DELINQUENT(LTF) LIST			
ONCO DUE FOLLOWUP			
ONCO DUE FOLLOWUP-ADM/DIS			
ONCO DUE FOLLOWUP-ADM/DIS-HDR			
ONCO DUE FOLLOWUP-HDR			
ONCO DUE FOLLOWUP/TERMDIG			
ONCO DUE FOLLOWUP/TERMDIG-HDR			
ONCO F/U HISTORY (NEW)			
ONCO FOLLOW-UP STATUS LIST			
ONCO FOLLOWUP HISTORY			
ONCO FOLLOWUP HISTORY-HDR			
ONCO FOLLOWUP PATIENT RPT			
ONCO FOLLOWUP PATIENT RPT-HDR			
ONCO FOLLOWUP STATUS RPT			
ONCO ICDO PATIENT LIST			
ONCO ICDO-SITE132			
ONCO ICDO-SITE132-HDR			
ONCO ICDO-SITE80			
ONCO ICDO-SITE80-HDR			
ONCO LAB-CASEFINDING REPORT			
ONCO LAB-CASEFINDING-HDR			
ONCO NEG-REPORT			
ONCO PATIENT INDX-ACOS			
ONCO PATIENT INDX-ACOS-HDR			
ONCO PATIENT INDX-EOVA132			
ONCO PATIENT INDX80			
ONCO PATIENT ONLY			
ONCO PATIENT ONLY-HDR			
ONCO PRIMARY EXTENT CODE AUDIT			
ONCO PRIMARY INFORMATION132			
ONCO PRIMARY SURGERY AUDIT			
ONCO PTF-CASEFINDING RPT			
ONCO PTF-CASEFINDING-HDR			
ONCO RAD-CASEFINDING RPT			
ONCO RAD-CASEFINDING-HDR			
ONCO SITE HEADING			
ONCO SITE-QA REPORT			
ONCO SITE/GP80			
ONCO SITE/GP80-HDR			
ONCO SITE80			
ONCO SITE80-HEADER			
ONCO SUSPENSE			
ONCO SUSPENSE-ALL/TERMDIG			
####################	####################	####################	
####################	####################	####################	
####################	####################	####################	
####################	####################	####################	
####################	####################	####################	
